5 Psychedelic Apps

These 5 Apps Are Made for Taking Psychedelics

,
Taking psychedelics? There's an app for that. These companies are leading the way with trip guides, support, and more.

MindMed’s LSD Neutralizer is GENIUS: MindMed Stock’s Massive Opportunity (MMED/MMEDF) ๐Ÿš€

In this video, I discuss how MindMed's LSD Neutralizer is GENIUS: MindMed Stock's Massive Opportunity (MMED/MMEDF. ๐Ÿ”ฅ MindMed has had a impressive run up in 2020. The MMED stock is up nearly 1,130% and what we all wonder is : Could MindMed Stock keep on rising? With a larger psychedelic pipeline than Compass Pathways (CMPS), MindMed has made huge advancements in 2020, one of which is its LSD Neutralizer Technology To Shorten and Stop LSD Trips, which is groundbreaking news for all players in the psychedelic medicines industry. MindMed has a handful of exciting programs in the works, some of which have important milestones coming up this year. Project Lucy is one of these programs, using therapeutic doses of LSD to treat anxiety disorders. If this gets the go-ahead from regulators, it will proceed with a clinical trial investigating LSD for anxiety disorders. If that happens, the mindmed stock could get a big boost. Another boost could be MindMed's potential uplisiting on to the Nasdaq. Currently, the MindMed Stock trades on the Canadian exchange NEO under the symbol MMED. MindMed is also traded in the United States under the symbol MMEDF and in Germany under the symbol MMQ. Remember to Like, Subscribe, and SMAH that notifications bell to keep up to date on all the latest Psychedelic Stocks news! Follow us on social media! Instagram: @psychedelicinvestor Facebook: @thepsychedelicinvestor Music: www.bensound.com DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments. #MindMedStock #MindMed #MMED #MMEDF
Psychedelic Trend Predictions 2021

7 Psychedelic Trend Predictions for 2021

The momentum for psychedelics is snowballing, and 2021 is expected to be an even bigger and better year for the industry.

Why I’m More Excited About MindMed’s 18-MC than its LSD treatments

Happy Holidays guys! I ๐ŸŽ„๐Ÿ™ƒ In this episode we'll cover the many reasons why I'm more excited about MindMed's 18-MC than its LSD treatments. As I mentioned in my previous video, the unfortunate fact is that the world is dealing with a second hidden epidemic: The Opioid Crisis. MindMed ( MMED/ MMEDF ) has a solution: 18-MC. Yes, MindMed has a diverse pipeline with other experiential drugs such as LSD for anxiety and psilocybin to treat ADHD. However, this psychedelic medicines company has its own proprietary compound (18-MC) to treat addiction which, if successful, cannot be copied by the upcoming competition. Keep watching to learn more about MindMed's plan to end the opioid crisis with 18-MC. We may have a light at the end of the tunnel, and MindMed could potentially defeat the opioid epidemic threat, making MMED one of the best stocks for 2021. Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news! Follow us on social media! Instagram: @psychedelicinvestor Facebook: @thepsychedelicinvestor Music: www.bensound.com DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments. #MindMed #MMED #MMEDF #mindmedstock

MindMed ‘s Plan to END the Opioid Epidemic (How MMED / MMEDF Could Make Billions)

It is an unfortunate fact that the world is dealing with a second hidden epidemic: The Opioid Crisis. Luckily, MindMed ( MMED/ MMEDF ) has a solution: 18-MC. This Psychedelic Medicines company, which may soon be uplisted to the Nasdaq, is testing it's ibogaine derivative to heal those effected by opioid addiction, whether from fentanyl or doctors' prescriptions. We may have a light at the end of the tunnel, and the Opioid Epidemic may be defeated. This makes MindMed one of the best stocks for 2021. How much could this be worth? Tune in to find out! Remember to Like, Subscribe, and SMAH that notifications bell to keep up to date on all the latest Psychedelic Stocks news! Follow us on social media! Instagram: @psychedelicinvestor Facebook: @thepsychedelicinvestor Music: www.bensound.com DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments. Resources https://www.cdc.gov/nchs/pressroom/podcasts/20190911/20190911.htm https://www.ncbi.nlm.nih.gov/books/NBK541390/#:~:text=Morethan2millionpeople,diseasestraumaandsuicide. https://www.hhs.gov/opioids/about-the-epidemic/opioid-crisis-statistics/index.html#:~:text=In2018anestimated10.3,and808000peopleusedheroin.&text=Appropriateprescribingofopioidsis,andsafetyofMedicarebeneficiaries. https://www.ccsa.ca/opioids#:~:text=Canadaisinthemidst,publichealthandsafetyconcern. https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.17477 https://www.publichealthontario.ca/-/media/documents/o/2020/opioid-mortality-covid-surveillance-report.pdf?la=en https://www.camh.ca/en/health-info/mental-illness-and-addiction-index/opioid-addiction https://www.drugabuse.gov/publications/drugs-brains-behavior-science-addiction/treatment-recovery https://preprod.drugfree.org/article/relapse-overdose/ https://mindmed.co/psychedelic-inspired/#scroll_section-1 https://americanaddictioncenters.org/meth-treatment/success-rate-for-ibogaine https://americanaddictioncenters.org/meth-treatment/success-rate-for-ibogaine https://s3.ca-central-1.amazonaws.com/ibosafe-pdf-resources/Ibogaine/Treating+drug+dependence+with+the+aid+of+ibogaine_a+retrospective+study.pdf https://americanaddictioncenters.org/meth-treatment/success-rate-for-ibogaine https://thethirdwave.co/psychedelics/ibogaine/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4382526/#:~:text=Theantiaddictiondrugibogainecertainlyaffectstheheartand,ibogaine'spotentiallylifethreateningcardiotoxicity. https://mindmed.co/wp-content/uploads/2020/11/investor-deck.pdf https://www.ibogainealliance.org/18-mc/ https://mindmed.co/wp-content/uploads/2020/11/investor-deck.pdf #MindMed #MMED #MMEDF #MindMedNews #OpioidEpidemic #OpioidCrisis #MindMedStock #18MC #18-MC #PsychedelicStocks
Queenโ€™s University Launches Psychedelic Research Collaborative

Psychedelic Business News Spotlight: December 17, 2020

The UK gets its first psychedelic VC fund, psychedelic treatment for Parkinson's, and more business news.

Is it TOO LATE to Buy MindMed (MMED) ๐Ÿ„: Part deux (Plus Clinical Trial Updates!)

Is it TOO LATE to Buy MindMed (MMED / MMEDF)? NO! Of course not. We are at the beginning of the Psychedelic Stocks boom. Despite the recent MASSIVE runup, the stock has skyrocketed more than 4x in the last week (due to a possible inclusion into the Nasdaq, clinical trial updates and hype), MindMed still has a long way to go yet. MMEDF is definitely one of the best stocks for 2021 Hope you guys enjoy this video! Note, the stock has dropped a bit since filming, but everything still holds. Plus, Iโ€™m sure it will clear that 4 dollar mark again within days! Follow us on social media! Instagram: @psychedelicinvestor Facebook: @thepsychedelicinvestor Music: www.bensound.com DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments. Resources: https://www.thestreet.com/investing/n... https://www.prnewswire.com/news-relea... #MindMed #MMED #mindmedstock #MMEDF #PsychedelicStocks #PennyStocks #Investing #BestStocksFor2021

Will MindMed (MMED) join the NASDAQ? (What Will Happen To the Stock If It Does?)

Will MindMed get uplisted on the NASDAQ and what will happen to its stock price if the company is accepted? These are all questions we've been wondering ๐Ÿ˜ฑ. The requirements to join NASDAQ have been less than clear for investors. It has been more than six weeks since MindMed (MMED) applied for an uplisting on NASDAQ and retail investors have been waiting for news while MindMed's stock price has been reaching all times highs๐Ÿ”ฅ. In this video, we'll discuss what the actual requirements are, what will happen to MMED's stock price if the company gets uplisted, and whether retail investors should be influenced by the news ( good or bad). Hope you guys enjoy this video! Follow us on social media! Instagram: @psychedelicinvestor Facebook: @thepsychedelicinvestor Music: www.bensound.com DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments. #MindMed #mmed #mindmedstock Resources: https://www.thestreet.com/investing/nasdaq-listing-requirements-15092402?fbclid=IwAR09DXpV8nLoMgXrJ7Ru1A8GHk53BHQBakLFI1xnHLw-ZDzY7nZjp88D0CU

Psychedelic Business News Spotlight: December 10, 2020

This week in psychedelic business news: Motley Fool bets on MindMed, mushrooms go from Jamaica to Canada, and more.
Singapore Begins Administering Ketamine-Type Therapy for Depression

Psychedelic Life Science Company Cybin Acquires Ketamine Drug Maker Adelia Therapeutics

Cybin Inc., has acquired the ketamine drug Spravato manufacturer Adelia Therapeutics in its first major acquisition.